Terapio
US-based Terapio Corporation develops therapeutics to combat radiation-induced cell damage globally.
Founded
2005US-based Terapio Corporation develops therapeutics to combat radiation-induced cell damage globally.
Founded in Austin, United States, Terapio Corporation is a biopharmaceutical company dedicated to developing therapeutics aimed at increasing cellular resilience against radiation-induced oxidative damage. Their core mission is to enhance global health by providing innovative solutions for radiation exposure. The company offers advanced TENS (Transcutaneous Electrical Nerve Stimulation) machines, which are certified medical devices designed to provide natural pain relief without medication, targeting both chronic and acute pain sufferers.
Terapio has garnered attention for its cutting-edge approach to pain management and radiation therapy. Notable affiliated individuals and investors include experts in biopharmaceuticals and medical device innovation. The company's key achievements include the successful development and certification of their TENS units, which have been adopted by healthcare professionals worldwide. Terapio's impact is significant in both the biopharmaceutical and medical device markets, offering effective, non-invasive solutions for pain relief and cellular protection.
Companies similar to Terapio include Therabody, PhotoThera, Thermaquil and Zenith Technical Innovations.
Terapio was founded in 2005.
Terapio's headquarters is located in Austin, TX, US.
Terapio's most recent funding round was for $780k (USD) in July 2015.
As of Jul 21, 2015, Terapio has disclosed funding of $7.5M (USD). Undisclosed round amounts are excluded.
Terapio has 7 employees as of Feb 4, 2024.
thermxtherapy.com
